Biological functions
| Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
|---|---|---|---|---|---|---|---|---|---|---|
| KEGG | hsa00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 25/5507 | 26/8135 | 0.0005192 | 0.001734 | 0.0008909 | 25 | RABC79 | |
| KEGG | hsa01250 | Biosynthesis of nucleotide sugars | 34/5507 | 37/8135 | 0.0005337 | 0.001765 | 0.0009067 | 34 | RABC79 | |
| KEGG | hsa04810 | Regulation of actin cytoskeleton | 169/5507 | 218/8135 | 0.0007948 | 0.002603 | 0.001337 | 169 | RABC79 | |
| KEGG | hsa05110 | Vibrio cholerae infection | 44/5507 | 50/8135 | 0.0008335 | 0.002703 | 0.001388 | 44 | RABC79 | |
| KEGG | hsa05133 | Pertussis | 64/5507 | 76/8135 | 0.0008657 | 0.00278 | 0.001428 | 64 | RABC79 | |
| KEGG | hsa00310 | Lysine degradation | 54/5507 | 63/8135 | 0.0009154 | 0.002912 | 0.001496 | 54 | RABC79 | |
| KEGG | hsa04621 | NOD-like receptor signaling pathway | 144/5507 | 184/8135 | 0.0009279 | 0.002924 | 0.001502 | 144 | RABC79 | |
| KEGG | hsa04931 | Insulin resistance | 88/5507 | 108/8135 | 0.0009402 | 0.002935 | 0.001508 | 88 | RABC79 | |
| KEGG | hsa03460 | Fanconi anemia pathway | 47/5507 | 54/8135 | 0.0009618 | 0.002974 | 0.001528 | 47 | RABC79 | |
| KEGG | hsa04720 | Long-term potentiation | 57/5507 | 67/8135 | 0.0009851 | 0.003019 | 0.001551 | 57 | RABC79 | |
| KEGG | hsa05166 | Human T-cell leukemia virus 1 infection | 93/1759 | 222/8135 | 0.00000000000459 | 0.00000000153 | 0.00000000111 | 93 | RABC37 | |
| KEGG | hsa05169 | Epstein-Barr virus infection | 85/1759 | 202/8135 | 0.0000000000295 | 0.00000000493 | 0.00000000356 | 85 | RABC37 | |
| KEGG | hsa04658 | Th1 and Th2 cell differentiation | 42/1759 | 92/8135 | 0.000000212 | 0.0000236 | 0.0000171 | 42 | RABC37 | |
| KEGG | hsa04659 | Th17 cell differentiation | 46/1759 | 108/8135 | 0.000000692 | 0.0000577 | 0.0000417 | 46 | RABC37 | |
| KEGG | hsa05170 | Human immunodeficiency virus 1 infection | 76/1759 | 212/8135 | 0.00000108 | 0.0000638 | 0.0000461 | 76 | RABC37 | |
| KEGG | hsa04110 | Cell cycle | 51/1759 | 126/8135 | 0.00000115 | 0.0000638 | 0.0000461 | 51 | RABC37 | |
| KEGG | hsa05164 | Influenza A | 64/1759 | 171/8135 | 0.00000142 | 0.0000678 | 0.000049 | 64 | RABC37 | |
| KEGG | hsa04380 | Osteoclast differentiation | 51/1759 | 128/8135 | 0.000002 | 0.0000837 | 0.0000604 | 51 | RABC37 | |
| KEGG | hsa05162 | Measles | 54/1759 | 139/8135 | 0.00000254 | 0.0000942 | 0.000068 | 54 | RABC37 | |
| KEGG | hsa04660 | T cell receptor signaling pathway | 43/1759 | 104/8135 | 0.00000407 | 0.000136 | 0.0000982 | 43 | RABC37 | |
| KEGG | hsa04010 | MAPK signaling pathway | 96/1759 | 294/8135 | 0.00000534 | 0.0001622 | 0.0001171 | 96 | RABC37 | |
| KEGG | hsa03440 | Homologous recombination | 22/1759 | 41/8135 | 0.00000675 | 0.0001878 | 0.0001355 | 22 | RABC37 | |
| KEGG | hsa03030 | DNA replication | 20/1759 | 36/8135 | 0.00000883 | 0.0002269 | 0.0001637 | 20 | RABC37 | |
| KEGG | hsa05161 | Hepatitis B | 58/1759 | 162/8135 | 0.000021 | 0.0005 | 0.0003609 | 58 | RABC37 | |
| KEGG | hsa05203 | Viral carcinogenesis | 69/1759 | 204/8135 | 0.0000318 | 0.0007071 | 0.0005103 | 69 | RABC37 | |
| KEGG | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 66/1759 | 194/8135 | 0.0000382 | 0.0007975 | 0.0005755 | 66 | RABC37 | |
| KEGG | hsa04630 | JAK-STAT signaling pathway | 57/1759 | 162/8135 | 0.0000437 | 0.0008582 | 0.0006194 | 57 | RABC37 | |
| KEGG | hsa04668 | TNF signaling pathway | 42/1759 | 112/8135 | 0.0000848 | 0.001573 | 0.001135 | 42 | RABC37 | |
| KEGG | hsa04064 | NF-kappa B signaling pathway | 39/1759 | 104/8135 | 0.0001499 | 0.002635 | 0.001902 | 39 | RABC37 | |
| KEGG | hsa04935 | Growth hormone synthesis, secretion and action | 43/1759 | 119/8135 | 0.0001869 | 0.003051 | 0.002202 | 43 | RABC37 |